MCKMcKesson Corporation

$115B

Q2 2021 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$60.8B+5.5% YoY

Gross Profit

$2.9B4.7% margin

Operating Income

$804M1.3% margin

Net Income

$577M0.9% margin

EPS (Diluted)

$3.54

QoQ Revenue Growth

+9.2%

Cash Flow

Operating Cash Flow

$1.0B

Free Cash Flow

$873M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$61.6B

Total Liabilities

$54.2B

Stockholders' Equity

$5.9B

Cash & Equivalents

$3.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60.8B	$57.6B	+5.5%
Gross Profit	$2.9B	$2.7B	+3.9%
Operating Income	$804M	$671M	+19.8%
Net Income	$577M	-$730M	+179.0%

Revenue Segments

U.S. Pharmaceutical Segment

$48.1B79%

International Segment

$9.5B16%

Medical-Surgical Solutions Segment

$2.5B4%

Prescription Technology Solutions

$668M1%

MCK Q2 2021 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena